| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.01 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.00065 | 1 |